Results

Total Results: 2,505 records

Showing results for "diseases".

361. Topic 0509 Home-based Primary Care Interventions NSD FINAL SJ-2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0599-131115.pdf
     June 20, 2013 - acknowledges uncertainty regarding the comparative effectiveness related to outcomes such as mortality and disease … Elderly, disabled or homebound adults living in the community who require primary care for a chronic disease … disability Intervention(s): Home-based primary care programs utilizing in-home visits for chronic disease … nursing home admissions, Health care utilization (e.g., ER visits, hospital admissions), cost, relevant disease-specific

362. 04-E029-1 Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
     December 01, 2011 - Incidence of metastatic disease d. Quality of life e. Costs 5. … No more than 20 percent of the study sample could exhibit more advanced disease. … We also extracted definitions of disease progression. … additional basic and clinical research is needed to more accurately classify or predict those men whose diseases … No trial provided results from comparisons of AS with RP or RT in men with localized diseases.

363. Juvenile-Arthritis-Dmards Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
     March 14, 2013 - CER # 28: Disease-Modifying Antirheumatic Drugs (DMARDs) in Children with Juvenile Idiopathic Arthritis … Lancet, and the New England Journal of Medicine) and five specialty journals (Annals of the Rheumatic Diseases … The ACR Pediatric 30 is also a relative measure of disease activity and not a measure of current disease … Of Internal Medicine BMJ JAMA Lancet New England Journal Of Medicine Annals of the Rheumatic Diseases … The ACR Pediatric 30 is also a relative measure of disease activity and not a measure of current disease

364. Juvenile-Arthritis-Dmards Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
     March 14, 2013 - CER # 28: Disease-Modifying Antirheumatic Drugs (DMARDs) in Children with Juvenile Idiopathic Arthritis … Lancet, and the New England Journal of Medicine) and five specialty journals (Annals of the Rheumatic Diseases … The ACR Pediatric 30 is also a relative measure of disease activity and not a measure of current disease … Of Internal Medicine BMJ JAMA Lancet New England Journal Of Medicine Annals of the Rheumatic Diseases … The ACR Pediatric 30 is also a relative measure of disease activity and not a measure of current disease

365. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 13: Pulmonary Disease … Slowing disease progression could lead to improved quality of life and reduced costs. … None of these approaches halts disease progression. … exacerbations, which may slow disease progression. … Slowed disease progression could lead to improved patient quality of life and reduced costs.

366. Microsoft Word - finbody.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
     January 01, 2007 - diffuse atherosclerotic vascular diseases.5,6 In the United States 12 to 14 percent of new patients … group of patients with unilateral disease. … A history or markers of some cardiovascular diseases were associated with increased mortality, poor … Human Services/National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases … Renal angioplasty for renovascular disease: a reappraisal.

367. Glaucoma-Treatment Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-treatment_research-protocol.pdf
     November 16, 2010 - definition of visual impairment to the definition included in the International Classification of Diseases … Ocular surface disease 8. Retinal tear and detachment 9. Patient discomfort 10. … Centers for Disease Control and Prevention. … Classification of Diseases, Functioning, and Disability Web page. … International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM).

368. Research White Paper Patient- or Participant-Generated Registries Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/patient-participant-generated-registries-guide-3rd-ed-addendum-white-paper.pdf
     February 01, 2018 - Evolution and Variation The phenomenon of individuals affected by diseases establishing registries … history of a disease. … able to help generate evidence to support the development of treatment guidelines, especially for diseases … into care coordination and practice guidelines has become a model for other diseases.19, 73-84 Planning … Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal

369. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
     December 15, 2010 - Ischemic heart disease CVD surgery and procedures Arrhythmias Quality of life Other heart disease … o Congestive heart failure o Valvular disease • Cerebrovascular disease o All stroke o Hemorrhagic … Use of complementary therapies in patients with cardiovascular disease. … Use of herbal products and potential interactions in patients with cardiovascular diseases. … Herbal medicine for the treatment of cardiovascular disease: clinical considerations.

370. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
     January 01, 2007 - Peripheral vascular disease. … morbidity, microvascular disease, and peripheral vascular disease. … lactic acidosis would help determine the safety of using this medication in populations with comorbid diseases … , congestive heart failure, liver disease, or psychiatric disease. … medications in effects on peripheral vascular disease. 2e.

371. Disposition of Comments: Comparative Effectiveness Review No. 273_Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-273-anal-cancer-disposition-comments.pdf
     August 20, 2024 - For rare diseases such as nonmetastatic squamous cell anal cancer, regulatory agencies have published … Disease - specific mortality may reflect better the impact of therapies for localized SCCA on pts survival … Discussion and Conclusions “Large prospective research studies are difficult to conduct for a rare disease … prospective research studies are difficult to conduct in developed countries where SCCA is a rare disease … Example: I would state CRT 5FU/MMC is superior to 5FU/RT in DFS and LR disease instead of saying 5FU

372. Cad-Women-Diagnosis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_executive.pdf
     June 01, 2012 - Comparative Effectiveness Review Number 58 Noninvasive Technologies for the Diagnosis of Coronary Artery Disease … in Women Executive Summary Background Cardiovascular disease is the leading cause of mortality for … Current diagnostic concepts to detect coronary artery disease in women. … Non-invasive imaging for coronary artery disease. Technology Assessment. … Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women.

373. S143 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s143.pdf
     October 01, 2007 - medical service from a provider with a diagnosis coded according to International Classification of Diseases … in the past year 0.96 0.54 �0.01 0.74 0.83 0.12 Mean no. cardiovascular disease-related diagnoses … 0.25 0.17 �0.01 0.21 0.23 0.21 Mean no. cardiovascular disease-related hospitalizations in the past … Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. … The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.

374. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-applicability.ppt
     June 01, 2012 - Spectrum effect The severity or type of disease may affect test accuracy. … Secular trends in population risk and disease prevalence Prevalence is tied to disease definitions that … A simple change in definition can have a great impact on disease prevalence. … be diagnosed and have the course of their disease altered. … Has the treatment of the related disease improved or changed?

375. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-applicability.ppt
     June 01, 2012 - Spectrum effect The severity or type of disease may affect test accuracy. … Secular trends in population risk and disease prevalence Prevalence is tied to disease definitions that … A simple change in definition can have a great impact on disease prevalence. … be diagnosed and have the course of their disease altered. … Has the treatment of the related disease improved or changed?

376. Emergency Medical Service/911 Workforce Mental or Behaviorial Health Issues (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/ems-911-workforce-topic-development-brief.pdf
     February 01, 2022 - Burn-out an "occupational phenomenon:: International Classification of Diseases. … The Journal of nervous and mental disease. 2008 Dec;196(12):912-8. doi: 10.1097/NMD.0b013e31818ec95d … BMC infectious diseases. 2010 Nov 9;10:322. doi: 10.1186/1471-2334-10-322. … The Journal of nervous and mental disease. 2015 Mar;203(3):205-9. … The Journal of nervous and mental disease. 2017 Feb;205(2):154-60. doi: 10.1097/nmd.0000000000000563

377. Medication-Adherence-Interventions Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-adherence-interventions_executive.pdf
     September 01, 2012 - Among patients with chronic diseases with self- administered medication prescribed by a provider, what … Among patients with chronic diseases with self- administered medication prescribed by a provider, what … ,67-74 depression,33, 48, 75-86 glaucoma,87 multiple sclerosis,88 musculoskeletal diseases,89-91 and … For musculoskeletal diseases, we found three trials that used interventions with no common features. … Noncommunicable Diseases and Mental Health Cluster.

378. Updating the Framework for AHRQ’s National Healthcare Quality and Disparities Report (NHQDR) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-framework-protocol.pdf
     September 06, 2023 - provides users with the latest available findings on care quality and access to healthcare stratified by diseases … The Centers for Disease Control and Prevention (CDC) defines health disparities as preventable differences … in the burden of disease, injury, violence, or in opportunities to achieve optimal health experienced … Quality indicators for acute cardiovascular diseases: a scoping review.

379. Disposition of Comments_Comparative Effectiveness Review No. 245: Breast Reconstruction After Mastectomy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-245-breast-reconstruction-after-mastectomy-disposition-comments.pdf
     October 01, 2021 - well-designed published studies indicating statistically significant increases in symptoms or related diseases … , and researchers have reported statistically significant increases in these symptoms and related diseases

380. Hypertension-Pulmonary-Arterial Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
     April 01, 2013 - 1.4.2 HIV infection 1.4.3 Portal hypertension 1.4.4 Congenital heart diseases … dysfunction 2.3 Valvular disease 3. … Pulmonary hypertension owing to lung diseases and/or hypoxemia 3.1 Chronic obstructive pulmonary … disease 3.2 Interstitial lung disease 3.3 Other pulmonary diseases with mixed restrictive … , or chronic obstructive pulmonary disease.